In the published article, there was an error regarding the definition of disease progression according to PERCIMT criteria.
A correction has been made to 2. Reporting schemes and classifications, 2.1. Therapy response assessment with 18F-FDG PET, 2.1.4. PET Response Evaluation Criteria for Immunotherapy (PERCIMT), paragraph 2.
This sentence previously stated:
“Disease progression is determined in the following 3 scenarios: (1) when there are 4 or more new lesions measuring less than 10 mm in their functional diameter, (2) when there are 3 or more new lesions also with functional diameter below 10 mm, or (3) when there are 2 or more new lesions with a functional diameter greater than 15 mm.”
The corrected sentence appears below:
“Disease progression is determined in the following 3 scenarios: (1) when there are 4 or more new lesions measuring less than 10 mm in their functional diameter, (2) when there are 3 or more new lesions with functional diameter greater than 10 mm, or (3) when there are 2 or more new lesions with a functional diameter greater than 15 mm.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
PET, Deauville, Krenning, PROMISE, immunotherapy, head and neck cancer
Citation
Murad V, Kulanthaivelu R, Ortega C, Veit-Haibach P and Metser U (2023) Corrigendum: Standardized classification schemes in reporting oncologic PET/CT. Front. Med. 10:1324108. doi: 10.3389/fmed.2023.1324108
Received
19 October 2023
Accepted
20 October 2023
Published
01 November 2023
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
10 - 2023
Updates
Copyright
© 2023 Murad, Kulanthaivelu, Ortega, Veit-Haibach and Metser.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ur Metser Ur.metser@uhn.ca
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.